Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Qian Zhou, MD"'
Autor:
Constantin Mork, MD, Otmar Pfister, MD, Luca Koechlin, MD, Simon Scheifele, Anne Morgen, Lukas Altwegg, MD, David Heppel, MD, Denis Berdajs, MD, Ayham Darwisch, MD, Michael Kuehne, MD, Oliver Reuthebuch, MD, Ulrich Schurr, MD, Martin Siegemund, MD, Friedrich Eckstein, MD, David Santer, MD, PhD, Qian Zhou, MD
Publikováno v:
CJC Open, Vol 3, Iss 10, Pp 1313-1315 (2021)
A 70-year-old female heart failure patient could not be weaned from temporary left ventricular mechanical support with Impella CP (Abiomed Inc, Danvers, MA) after myocardial infarction; therefore, she underwent left ventricular assist device implanta
Externí odkaz:
https://doaj.org/article/94beca3e06ba4d319350e6dd1c14aca0
Autor:
Yayan Yang BS, Qian Feng PhD, Chuanfeng Ding BS, Wei Kang PhD, Xiufeng Xiao PhD, Yongsheng Yu PhD, Qian Zhou MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Although Epirubicin (EPI) is a commonly used anthracycline for the treatment of breast cancer in clinic, the serious side effects limit its long-term administration including myelosuppression and cardiomyopathy. Nanomedicines have been widely utilize
Externí odkaz:
https://doaj.org/article/cd6966d960844f46acb460ff8ced536f
Autor:
Wei Kang PhD, Chuanfeng Ding BM, Danni Zheng BS, Xiao Ma BS, Lun Yi BS, Xinyi Tong BS, Chuang Wu MD, Chuang Xue PhD, Yongsheng Yu PhD, Qian Zhou MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Conventional antibody-based targeted cancer therapy is one of the most promising avenues of successful cancer treatment, with the potential to reduce toxic side effects to healthy cells surrounding tumor cells. However, the full potential of antibodi
Externí odkaz:
https://doaj.org/article/643a7913918649fca88017b5c2f057fb